158 related articles for article (PubMed ID: 11095400)
1. Protein tyrosine kinases in malignant melanoma.
Easty DJ; Bennett DC
Melanoma Res; 2000 Oct; 10(5):401-11. PubMed ID: 11095400
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphate in melanoma progression.
McArdle L; Bergin O; Fallowfield ME; Dervan PA; Easty DJ
Br J Dermatol; 2003 Aug; 149(2):289-95. PubMed ID: 12932234
[TBL] [Abstract][Full Text] [Related]
3. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis.
Easty DJ; Herlyn M; Bennett DC
Int J Cancer; 1995 Jan; 60(1):129-36. PubMed ID: 7814145
[TBL] [Abstract][Full Text] [Related]
4. Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.
Easty DJ; Ganz SE; Farr CJ; Lai C; Herlyn M; Bennett DC
J Invest Dermatol; 1993 Nov; 101(5):679-84. PubMed ID: 8228328
[TBL] [Abstract][Full Text] [Related]
5. c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas.
Funasaka Y; Boulton T; Cobb M; Yarden Y; Fan B; Lyman SD; Williams DE; Anderson DM; Zakut R; Mishima Y
Mol Biol Cell; 1992 Feb; 3(2):197-209. PubMed ID: 1372524
[TBL] [Abstract][Full Text] [Related]
6. Receptor tyrosine kinases and their activation in melanoma.
Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
[TBL] [Abstract][Full Text] [Related]
7. Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes.
Halaban R; Fan B; Ahn J; Funasaka Y; Gitay-Goren H; Neufeld G
J Immunother (1991); 1992 Oct; 12(3):154-61. PubMed ID: 1445804
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase genes downregulated in melanoma.
McArdle L; Rafferty M; Maelandsmo GM; Bergin O; Farr CJ; Dervan PA; O'Loughlin S; Herlyn M; Easty DJ
J Invest Dermatol; 2001 Nov; 117(5):1255-60. PubMed ID: 11710941
[TBL] [Abstract][Full Text] [Related]
9. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
[TBL] [Abstract][Full Text] [Related]
10. Growth factors and tyrosine protein kinases in normal and malignant melanocytes.
Halaban R
Cancer Metastasis Rev; 1991 Jun; 10(2):129-40. PubMed ID: 1873853
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of phosphatase gene expression in human melanoma.
McArdle L; Rafferty MM; Satyamoorthy K; Maelandsmo GM; Dervan PA; Herlyn M; Easty DJ
Br J Dermatol; 2005 May; 152(5):925-30. PubMed ID: 15888148
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinases: from viral oncogenes to developmental regulators.
Blaschke R; Andres AC; Reid HH; Zürcher G; Friis RR; Ziemiecki A
Behring Inst Mitt; 1991 Jul; (89):81-92. PubMed ID: 1930106
[TBL] [Abstract][Full Text] [Related]
14. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
15. Loss of c-kit expression in cultured melanoma cells.
Lassam N; Bickford S
Oncogene; 1992 Jan; 7(1):51-6. PubMed ID: 1371338
[TBL] [Abstract][Full Text] [Related]
16. Protein kinases in normal and transformed melanocytes.
Quong RY; Bickford ST; Ing YL; Terman B; Herlyn M; Lassam NJ
Melanoma Res; 1994 Oct; 4(5):313-9. PubMed ID: 7858416
[TBL] [Abstract][Full Text] [Related]
17. met and HGF-SF in normal melanocytes and melanoma cells.
Halaban R; Rubin JS; White W
EXS; 1993; 65():329-39. PubMed ID: 8380740
[TBL] [Abstract][Full Text] [Related]
18. Proliferation and malignant transformation of melanocytes.
Halaban R; Moellmann G
Crit Rev Oncog; 1991; 2(4):247-58. PubMed ID: 1958709
[TBL] [Abstract][Full Text] [Related]
19. Induction of different morphologic features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu, and E1a oncogenes.
Ramon y Cajal S; Suster S; Halaban R; Filvaroff E; Dotto GP
Am J Pathol; 1991 Feb; 138(2):349-58. PubMed ID: 1992762
[TBL] [Abstract][Full Text] [Related]
20. PTPs versus PTKs: the redox side of the coin.
Chiarugi P
Free Radic Res; 2005 Apr; 39(4):353-64. PubMed ID: 16028361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
